Crocatin A: Neolignan From Piper crocatum Leaves Exhibited Promising Potency Against Hepatitis C Virus

Authors: Wahyuni, Tutik Sri; Vincentius, David; Tumewu, Lidya; Ling, Moi Meng; Zakaria, Zainul Amiruddin; Salim, Emil; Hafid, Achmad Fuad

Source journal: TheScientificWorldJournal (2026-01-01)

DOI: 10.1155/tswj/6100455

Abstract

Hepatitis C virus (HCV) is a human pathogenic virus that infects approximately 50 million people worldwide. Current therapies are costly and may lead to drug resistance during prolonged treatment, highlighting the need for new antiviral agents. Piper crocatum has previously been reported to have anti-HCV activity. Accordingly, this study was aimed at isolating an active compound with anti-HCV activity and low cytotoxicity from the 70% ethanol extract of Piper crocatum. Isolation was performed using a bioassay-guided approach. Anti-HCV activity was evaluated in Huh7it-1 hepatocyte cells infected with the JFH1 strain. Structural elucidation of the isolated compound was carried out using (1)H and (13)C NMR spectroscopic analyses and comparison with published data. Bioassay-guided isolation of the 70% ethanol extract of Piper crocatum leaves resulted in the isolation of crocatin A, a neolignan compound with anti-HCV activity. The extract and crocatin A exhibited IC(50) values of 2.29 +/- 0.19 and 1.90 +/- 0.51 mug/mL, respectively. Both also had CC(50) values > 100 mug/mL against Huh7it-1 hepatocytes and the Vero cell line, indicating SI > 43.67 and > 52.63, respectively. Based on these findings, the extract and crocatin A possess anti-HCV activity while exhibiting no significant cytotoxicity toward the cell cultures used. The mode of action demonstrated stronger inhibition in the postentry step. Moreover, molecular docking was performed to predict the possible mechanism of action of the active compound, suggesting that crocatin A may interact favorably with the NS5B polymerase, potentially contributing to viral replication inhibition.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.